Ardelyx Set to Showcase Innovations at Global Healthcare Event

Author: Ryan Hughes Updated: 05-21-2025 08:17 AM

Ardelyx's Participation at the Global Healthcare Conference

Introduction to Ardelyx

Ardelyx, Inc. (Nasdaq: ARDX) is a pioneering biopharmaceutical company. With a strong focus on developing innovative treatments, Ardelyx aims to create first-in-class medicines to address significant unmet medical needs. The company's mission emphasizes the importance of providing solutions for challenging health issues.

Event Details

In early June, Ardelyx's President and CEO, Mike Raab, will participate in a fireside chat at the prestigious Jefferies Global Healthcare Conference. This event is scheduled for June, specifically at 8:10 am ET. The conference is set to take place in New York and draws many industry leaders and professionals to discuss advancements in healthcare.

Webcast Access

For those interested in the discussions led by Ardelyx, the live webcast will be available. You can find this on the Events and Presentations page of the Ardelyx website. Additionally, a replay of the session will be accessible for a limited time after the event, allowing more people to gain insights into Ardelyx's innovations.

About Ardelyx and Its Products

Innovative Product Portfolio

Ardelyx has successfully developed two commercial products currently available in the United States: IBSRELA (tenapanor) and XPHOZAH (tenapanor). These medications have gained approval for addressing specific medical conditions, showcasing the company's commitment to bringing effective solutions to market.

International Collaborations

The company also has strategic partnerships for the further development of tenapanor beyond U.S. borders. Notably, Kyowa Kirin takes the lead in marketing PHOZEVEL (tenapanor) in Japan, underscoring Ardelyx's global reach. Furthermore, a New Drug Application for tenapanor targeting hyperphosphatemia has received approval in China through collaboration with Fosun Pharma, marking another significant milestone in Ardelyx's international ambitions.

Commitment to Communication

Connectivity and Engagement

Ardelyx places a high value on engagement with its stakeholders. The company encourages individuals to connect via various platforms including X, LinkedIn, and Facebook, ensuring that crucial updates and insights are readily available to investors and healthcare professionals alike.

Investor Relations

For inquiries related to investments or media engagement, interested parties are invited to reach out to Caitlin Lowie at Ardelyx. By providing these contact details, Ardelyx demonstrates its dedication to transparency and communication within the industry.

Frequently Asked Questions

What is Ardelyx known for?

Ardelyx is known for developing innovative biopharmaceuticals, particularly focusing on first-in-class medicines that address unmet medical needs.

When is Ardelyx participating in the Jefferies Conference?

Ardelyx will participate in the Jefferies Global Healthcare Conference on June 4, at 8:10 am ET.

How can I access the Ardelyx webcast?

The live webcast can be accessed through the Events and Presentations page on the Ardelyx website.

What are Ardelyx's key products?

The key products include IBSRELA and XPHOZAH, both focusing on significant medical issues such as IBS and hyperphosphatemia.

Who should I contact for investor inquiries at Ardelyx?

For investor inquiries, Caitlin Lowie can be contacted directly via email at clowie@ardelyx.com.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.